Niveles de presión arterial en adultos indígenas Yanomami del Estado Amazonas, Venezuela

  • Alberto Piamo Morales Hospital General “Dr. José Gregorio Hernández”
  • Mayra García Rojas
  • Alma Nashaevda García Rojas
  • Erik Díaz González
Palabras clave: Yanomami, presión arterial, presión arterial sistólica, estilos de vida

Resumen

Introducción: Existen poblaciones que por razones aún no completamente estudiadas y comprendidas presentan niveles de presión arterial óptimos que determinan la ausencia de morbilidad y mortalidad relacionada con las afecciones cardiovasculares. Objetivo: Determinaron los niveles de presión arterial de adultos indígenas Yanomami ubicados en la serranía de Topirapecó en el Estado Amazonas en Venezuela. Métodos: Entre los meses de mayo a julio y diciembre de 2021, se realizó un estudio poblacional transversal en 271 adultos indígenas Yanomami de 20 años de edad o más. Se visitó en dos ocasiones cada shabono con la finalidad de realizarle medición de la presión arterial. Las orientaciones para cumplir con el protocolo de medición de presión arterial fueron impartidas en el idioma original de los Yanomami con el apoyo de un Agente Comunitario Yanomami de Atención Primaria de Salud. Resultados: El 93% de los individuos presentaron valores de presión arterial óptimos (<120 y <80) y 5,5% PA normal (<130 y <85). Solo se presentaron dos casos (0,7%) con HTA (Grado I). Los niveles promedios de PAS, PAD y PAM fueron 93,10 (±11,70); 60,66 (±9,87) y 71,48 (±9,77) mm Hg, respectivamente.  Conclusiones: Los Yanomami que viven en comunidades del área geográfica de la serranía de Tapirapecó presentan niveles óptimos de presión arterial, lo que les previene de comorbilidad asociada a la HTA, lo que indica que no constituye un problema de salud emergente entre los Yanomami.

Citas

1. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):165-182. doi: 10.1001/jama.2016.19043
2. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014. doi: 10.1038/nrdp.2018.14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477925/
3. Singh M, Raina S, Goswami S, Raj D. Are the tribal highlanders protected from hypertension? A meta-analysis on prevalence of hypertension among high altitude tribal population of India. Indian J Public Health. 2020;64(3):295-299. doi: 10.4103/ijph.IJPH_509_19. https://www.ijph.in/article.asp?issn=0019-557X;year=2020;volume=64;issue=3;spage=295;epage=299;aulast=Singh
4. Rizwan SA, Kumar R, Singh AK, Kusuma YS, Yadav K, Pandav CS. Prevalence of hypertension in Indian tribes: A systematic review and meta-analysis of observational studies. PLoS One 2014;9:e95896.
5. Tavares FG, Coimbra CE, Cardoso AM. Níveis tensionais de adultos indígenas Suruí, Rondônia, Brasil. Cien Saude Colet. 2013;18(5):1399-409.
6. Raina SK, Chander V, Prasher CL, Raina S. Prevalence of hypertension in a tribal land locked population at high altitude. Scientifica (Cairo). 2016;2016:3589720. doi: 10.1155/2016/3589720. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773562/
7. Mancilha CJ, Silva NAS, Carvalho JV, Lima JAC. Pressão arterial em seis Aldeias Yanomami. Arq Bras Cardiol 1991;56(6):477-82.
8. Mancilha CJ, Carvalho JV, Lima JAC, Silva NAS. Ausência de fatores de risco de doença coronária em índios Yanomami e influência da aculturação na pressão arterial. Arq Bras Cardiol 1992;59(4):275-83.
9. Cardoso AM, Mattos IE, Koifman RJ. Prevalência de fatores de risco para doenças cardiovasculares na população Guaraní-Mbyá do Estado do Rio de Janeiro. Cad Saude Publica. 2001;17(2):345-354.
10. Williams B, Mancia G, Spiering W, Agabiti RE, Azizi M, Burnier M, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
11. Yoshitomi Y, Nagakura C, Miyauchi A. Significance of mean blood pressure for blood pressure control. Int Heart J. 2005;46(4):691-9. doi: 10.1536/ihj.46.691.
12. Centers for Disease Control and Prevention. Hypertension [Internet] Atlanta (GA): Centers for Disease Control and Prevention; 2018. https://www.cdc.gov/nchs/fastats/hypertension.htm.
13. Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al China Hypertension Survey Investigators. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation. 2018;137(22):2344-2356. doi: 10.1161/CIRCULATIONAHA.117.032380.
14. Kim HC, Ihm SH, Kim GH, Kim JH, Kim KI, Lee HY, et al. 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension. Clin Hypertens. 2019;25:16. doi: 10.1186/s40885-019-0121-0. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31388451/
15. Souza FZA, Ferreira AA, Santos BD, Pierin AM. Prevalência de hipertensão arterial em indígenas do Brasil: uma revisão sistemática com meta-análise. Rev Esc Enferm USP. 2015;49(6):1016-26. doi: 10.1590 / S0080-623420150000600019.
16. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture. Circulation.1975;52(1):146-51.
17. Mancilha CJ, Silva NAS, Oliveira JM, Argulles E, Silva JAF. Pressão arterial e grupos sociais: estudo epidemiológico. Arq Bras Cardiol.1983;40(2):115-20.
18. Oliveira GF, Oliveira TRR, Rodrigues FF, Corrêa LF, Ikejiri AT, Casulari LA. Prevalência de diabetes melito e tolerância à glicose diminuída nos indígenas da Aldeia Jaguapiru, Brasil. Rev Panam Salud Pública. 2011:29(5):315-21.
19. Oliveira GF, Oliveira TR, Ikejiri AT, Andraus MP, Galvao TF, Silva MT, et al. Prevalence of hypertension and associated factors in an indigenous community of central Brazil: a population-based study. PLoS One. 2014;9(1):e86278. doi: 10.1371/journal.pone.0086278. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904906/
20. Fleming MM, Santos RV, Coimbra Junior CEA. Blood pressure levels of the Suruí and Zoró indians of the Brazilian amazon: group and sex-specific effects resulting from body composition, health status, and age. Hum Biol.1991;63(6):835-61.
21. Guerrero RF, Rodríguez MM, Sandoval HF, Alvarado RR. Prevalence of hypertension in indigenous inhabitants of traditional communities from the north of Mexico. J Hum Hypertens. 2000;14(9):555-9. doi: 10.1038/sj.jhh.1001067.
22. Foulds HJ, Warburton DE. The blood pressure and hypertension experience among North American Indigenous populations. J Hypertens. 2014;32(4):724-34. doi: 10.1097/HJH.0000000000000084.
23. Wang Z, Knight S, Wilson A, Rowley KG, Best JD, McDermott R, et al. Blood pressure and hypertension for Australian Aboriginal and Torres Strait Islander people. Eur J Cardiovasc Prev Rehabil. 2006;13(3):438-43. doi: 10.1097/00149831-200606000-00021.
24. Mulerova T, Uchasova E, Ogarkov M, Barbarash O. Genetic forms and pathophysiology of essential arterial hypertension in minor indigenous peoples of Russia. BMC Cardiovasc Disord. 2020;20(1):169. doi:10.1186/s12872-020-01464-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158150/
25. Orellana BM, Nuggent KM, Sanchez BH, Lopez GJ. Prevalence of hypertension and associated anthropometric risk factors in indigenous adults of Guatemala. J Prim Care Community Health. 2015;6(1):16-20. doi: 10.1177/2150131914544219. https://journals.sagepub.com/doi/10.1177/2150131914544219?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&
26. Stoddard P, Handley MA, Vargas Bustamante A, Schillinger D. The influence of indigenous status and community indigenous composition on obesity and diabetes among Mexican adults. Soc Sci Med. 2011;73(11):1635-43. doi: 10.1016/j.socscimed.2011.09.006.
27. Escobedo J, Chavira I, Martínez L, Velasco X, Escandón C, Cabral J. Diabetes and other glucose metabolism abnormalities in Mexican Zapotec and Mixe Indians. Diabet Med J Br Diabet Assoc. 2010;27(4):412–6.
28. Mendoza CE, Barajas OF, García OH, Cicerón AI, Martínez HA, Córdova EJ, et al. Metabolic syndrome in indigenous communities in Mexico: a descriptive and cross-sectional study. BMC Public Health. 2020;20(1):339. doi: 10.1186/s12889-020-8378-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076922/
29. Hung LL, Hsiu HF, Chen ML, Chang LC, Chen CY, Chen CM. The association between health risk behavior and metabolic syndrome of aborigines in Taiwan. Taipei City Med J. 2010;7:255–264.
30. Tsao YC, Li WC, Yeh WC, Ueng SW, Chiu SY, Chen JY. The association between metabolic syndrome and related factors among the community-dwelling indigenous population in Taiwan. Int J Environ Res Public Health. 2020;17(23):8958. doi:10.3390/ijerph17238958. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730304/
31. Anjos HNK, Toledo MJO, Mota LT, Previdelli ITS, Anjos AF, Saruhashi TR, et al. Prevalence of metabolic syndrome among Kaingang Native Americans in Southern Brazil. Braz Arch Biol Technol. 2011;54(1):81-9.
32. Coimbra Junior CEA, Santos RV, Welch JR, Cardoso AM, Souza MC, Garnelo L, et al. The first national survey of indigenous people's health and nutrition in Brazil: rationale, methodology, and overview of results. BMC Public Health. 2013;13(52)1471-90.
33. Santos KM, Tsutsui MLS, Galvão PPO, Mazzucchetti L, Rodrigues D, Gimeno SGA. Grau de atividade física e síndrome metabólica: um estudo transversal com indígenas Khisêdjê do Parque Indígena do Xingu, Brasil. Cad Saúde Pública. 2012;28(12):2327-38.
34. Mancilha CJ, Baruzzi RG, Howard PF, Poulter N, Alpers MP, Franco LJ, et al. Blood pressure in four remote populations in the INTERSALT Study. Hypertension. 1989;14(3)238-46.
35. Bloch KV, Coutinho ESF, Lôbo MSC, Oliveira JEP, Milech A. Pressão arterial, glicemia capilar e medidas antropométricas em uma população Yanomámi. Cad Saúde Publica 1993;9(4):428-38.
36. Mancilha CJ, Silva NAS. The Yanomami Indians in the intersalt Study. Arq Bras Cardiol 2003;80(3):295-300.
37. Balafa O, Kalaitzidis RG. Salt sensitivity and hypertension. J Hum Hypertens. 2021;35(3):184-192. doi: 10.1038/s41371-020-00407-1. https://pubmed.ncbi.nlm.nih.gov/32862203/
38. Graudal NA, Hubeck GT, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2020;12(12):CD004022. doi: 10.1002/14651858.CD004022.pub5. https://pubmed.ncbi.nlm.nih.gov/33314019/
39. Reyhani P, Azabdaftari F, Ebrahimi MM, Asghari JM, Shokrvash B. The predictors of high dietary salt intake among hypertensive patients in Iran. Int J Hypertens. 2020;2020:6748696. doi:10.1155/2020/6748696. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168708/
40. Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of obesity and severe obesity in US children, 1999-2016. Pediatrics. 2018;141(3):e20173459. doi:10.1542/peds.2017-3459
41. Ogden CL, Fryar CD, Martin CB, Freedman DS, Carroll MD, Gu Q, et al. Trends in Obesity Prevalence by Race and Hispanic Origin-1999-2000 to 2017-2018. JAMA. 2020;324(12):1208-1210. doi: 10.1001/jama.2020.14590. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32857101/
42. Hardy ST, Sakhuja S, Jaeger BC, Urbina EM, Suglia SF, Feig DI, et al. Trends in blood pressure and hypertension among US children and adolescents, 1999-2018. JAMA Netw Open. 2021;4(4):e213917. doi: 10.1001/jamanetworkopen.2021.3917. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017470/
43. Urbina EM, Mendizábal B, Becker RC, Daniels SR, Falkner BE, Hamdani G, et al. Association of Blood Pressure Level With Left Ventricular Mass in Adolescents. Hypertension. 2019;74(3):590-596. doi: 10.1161/HYPERTENSIONAHA.119.13027.
44. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT Jr, et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137(2):109-118. doi: 10.1161/CIRCULATIONAHA.117.032582. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29133599/
45. Cheung BMY, Or B, Fei Y, Tsoi MF. A 2020 Vision of Hypertension. Korean Circ J. 2020;50(6):469-475. doi:10.4070/kcj.2020.0067. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234844/
Publicado
2022-05-16
Sección
Artículo original